Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company ...
To bolster its financial resilience against UK flood risks, Flood Re has successfully launched its first catastrophe bond, ...
Perry Thomas, Chief Executive Officer (CEO) of Flood Re, has announced the successful completion of the company's debut ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback